Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06264128 · ClinicalTrials.gov registry record · NA
TPAP for Comfort in OSA
A NA study, sponsored by SleepRes.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT06264128: Completed NA study, sponsored by SleepRes.
NCT06264128 is a NA study that has completed, run by SleepRes. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06264128, a NA study, has completed, sponsored by SleepRes.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the pressure from the set pressure at the beginning of inspiration and does not return the pressure to the full set level until about halfway through expiration. The present study, TheraPAP Comfort, aims at assessing whether TPAP improves patient comfort vs. CPAP during supine wakefulness.
Primary Outcome
Compare the comfort level of CPAP at 9 cmH2O against TPAP dropped by 2+2 cmH2O
Interventions
- DEVICE CPAP
- DEVICE TPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2024-05-25 |
| Phase | NA |
What the finished NCT06264128 record still lists
NCT06264128 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which CPAP is the first listed.
NCT06264128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06264128 about?
NCT06264128 is a clinical study titled "TPAP for Comfort in OSA". TheraPAP is a prototype device (with full documented electrical and isolation safety) being developed by SleepRes for the treatment of obstructive sleep apnea (OSA) that can deliver either standard CPAP at a set pressure or what is called TPAP . TPAP is a pressure control algorithm that lowers the p...
What is the current status of trial NCT06264128?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2024-03-08. Estimated completion is 2024-05-25.
What interventions are being tested in trial NCT06264128?
The interventions under investigation include: CPAP (DEVICE), TPAP (DEVICE).
Who is sponsoring clinical trial NCT06264128?
This trial is sponsored by SleepRes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06264128's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI